ArticleAmerican journal of translational research2019

Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition.

Yinglu Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.